India Globalization Capital, Inc.
(NYSE Amex Equities : IGC)

( )
IGC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.80%61.580.0%$914.89m
NVAXNovavax, Inc. -5.99%98.30102.0%$790.47m
AMGNAmgen, Inc. -0.62%251.591.3%$725.25m
REGNRegeneron Pharmaceuticals, Inc. -0.08%640.342.5%$677.64m
GILDGilead Sciences, Inc. -1.06%75.611.0%$627.17m
BIIBBiogen, Inc. 4.41%280.191.6%$622.60m
VRTXVertex Pharmaceuticals, Inc. -1.05%295.921.9%$509.00m
ILMNIllumina, Inc. -0.61%369.873.5%$300.06m
ALXNAlexion Pharmaceuticals, Inc. -3.97%108.002.0%$219.47m
BMRNBioMarin Pharmaceutical, Inc. 0.59%128.734.3%$214.30m
SGENSeattle Genetics, Inc. -0.35%175.536.1%$200.21m
SRNESorrento Therapeutics, Inc. -1.22%7.291.8%$180.15m
IMMUImmunomedics, Inc. 0.95%41.5511.0%$179.47m
SRPTSarepta Therapeutics, Inc. 3.82%170.1513.9%$164.96m
ALNYAlnylam Pharmaceuticals, Inc. 0.26%160.428.5%$164.06m

Company Profile

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.